Effects of single and multiple doses of itraconazole on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein

被引:29
作者
Shimizu, Mikiko [1 ]
Uno, Tsukasa [1 ]
Sugawara, Kazunobu [1 ]
Tateishi, Tomonori [1 ]
机构
[1] Hirosaki Univ, Sch Med, Dept Clin Pharmacol, Hirosaki, Aomori 0368562, Japan
关键词
drug interaction; fexofenadine; itraconazole; pharmacokinetics; treatment period;
D O I
10.1111/j.1365-2125.2006.02689.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims We determined whether or not the extent of drug interaction of fexofenadine by itraconazole is time-dependent. Methods In a randomized two-phase crossover study, itraconazole was administered orally for 6 days, and, on days 1, 3 and 6, fexofenadine was administered simultaneously. On another occasion, fexofenadine was administered alone. Results Itraconazole increased fexofenadine AUC(0, infinity), and the % change for difference was 178% (95% CI 1235, 3379), 205% (95% CI 1539, 3319) and 169% (95% CI 1128, 2987) on days 1, 3 and 6 of the 6 day treatment, respectively. Conclusions The extent of drug interaction by itraconazole was not time-dependent.
引用
收藏
页码:372 / 376
页数:5
相关论文
共 18 条
[1]   Grapefruit juice-drug interactions [J].
Bailey, DG ;
Malcolm, J ;
Arnold, O ;
Spence, JD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (02) :101-110
[2]  
Cvetkovic M, 1999, DRUG METAB DISPOS, V27, P866
[3]   Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition [J].
Dresser, GK ;
Spence, JD ;
Bailey, DG .
CLINICAL PHARMACOKINETICS, 2000, 38 (01) :41-57
[4]   Itraconazole decreases renal clearance of digoxin [J].
Jalava, KM ;
Partanen, J ;
Neuvonen, PJ .
THERAPEUTIC DRUG MONITORING, 1997, 19 (06) :609-613
[5]   Effect of grapefruit juice dose on grapefruit juice-triazolam interaction:: repeated consumption prolongs triazolam half-life [J].
Lilja, JJ ;
Kivistö, KT ;
Backman, JT ;
Neuvonen, PJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 56 (05) :411-415
[6]   Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol [J].
Lilja, JJ ;
Backman, JT ;
Laitila, J ;
Luurila, H ;
Neuvonen, PJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (03) :192-198
[7]   Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1) [J].
Niemi, M ;
Kivistö, KT ;
Hofmann, U ;
Schwab, M ;
Eichelbaum, M ;
Fromm, MF .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (05) :602-604
[8]   Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human [J].
Nozawa, T ;
Imai, K ;
Nezu, JI ;
Tsuji, A ;
Tamai, I .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 308 (02) :438-445
[9]   The effect of the systemic antimycotics, itraconazole and fluconazole, on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam [J].
Olkkola, KT ;
Ahonen, J ;
Neuvonen, PJ .
ANESTHESIA AND ANALGESIA, 1996, 82 (03) :511-516
[10]   Fexofenadine transport in Caco-2 cells: Inhibition with verapamil and ritonavir [J].
Perloff, MD ;
von Moltke, LL ;
Greenblatt, DJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (11) :1269-1274